Laxatives are defined as chemical substances that help in improving stool mobility and bowel movement and thereby preventing constipation. Growing cases of medical disorders such as eating disorders and rising cases of constipation is expected to drive growth of the global laxatives market during the forecast period. Excessive consumption of laxatives can lead to various health complications including diarrhea, dehydration, chronic constipation, and blood in the stool. However, laxative abuse remains a common issue. According to a study published in National Center for Biotechnology Information (NCBI) in 2010, people abusing laxatives can be divided into four groups. The largest group is comprised of people suffering from eating disorders such as anorexia or bulimia, and prevalence of abuse in this group ranges from 10% to 60%, according to the same study. The remaining three categories are – individuals who began using laxatives when constipated but didn’t after getting better; individuals who are involved in sports activities such as weight lifting, and surreptitious laxative abusers.
Market Dynamics- Drivers
Increasing cases of constipation is expected to drive growth of the global laxatives market during the forecast period. Constipation is one of the most widely diagnosed gastrointestinal disorders across the globe. According to the report published by Canadian Digestive Health Foundation in 2014, 1 out of 4 people living in Canada recorded to have symptoms of constipation in 2014. Chronic constipation rates for women were almost twice as high as for men in Canada.
Moreover, growing cases of constipation were also observed in various developed countries such as the U.K. and the U.S. According to a report published by Coloplast—a global leading player in ostomy care, urology and continence care, and wound and skin care, 1 in 7 adults were affected by constipation during 2014 – 2015 in the UK. The condition was even worse for children, wherein 1 in 3 were affected by constipation during 2014-2015.
These observations are similar in emerging economies such as China, Brazil, and India. According to Abbott Gut-Health Survey, around 14% of the urban population in India suffered from chronic constipation in 2015. Since these people are from urban areas, where healthcare services improving rapidly, the number patients is expected to increase thereby accelerating growth of the market.
Rising cases of eating disorders and growing availability over-the-counter laxatives is expected to propel the global laxatives market growth over the forecast period. Many developed countries such as Germany, Australia, the U.S., and the U.K. have witnessed massive surge in cases of eating disorders. A report commissioned by Beat in 2015, estimated that over 725,000 people were affected by the disease in UK. According to South Carolina Department of Mental Health (DMH) around 8 million people, including seven million women and one million men in the U.S. were recorded suffering from an eating disorder, in 2015.
Patients with eating disorders are most likely to overuse laxatives. Furthermore, laxatives are available as OTC, which has led to its excessive use thereby propelling the market growth.
Market Dynamics- Restraints
Unwillingness of patients to consult doctors regarding constipation is expected to hinder the global laxatives market growth over the forecast period. A large pool of patients are embarrassed to consult doctors regarding constipation, even in the developed countries. According to the study released by Coloplast in 2015, around 1 in 5 (i.e. 20%) people in UK, reportedly felt embarrassed to talk to their GP about constipation. This has resulted in underreporting of the people suffering from this condition.
Furthermore, in emerging economies such as India, people do not feel necessary to consult doctor for constipation, especially in rural parts. This negligence is due to low accessibility to healthcare facility, lack of literacy, higher self-medication practices, and low per-capita income. Hence, such factors are expected to hinder the market growth in the near future.
Major companies involved in the global laxatives market are AstraZeneca plc, Boehringer Ingelheim GmbH, Bayer AG, GlaxoSmithKline plc, Abbott Laboratories, Takeda Pharmaceutical Company Ltd, Teva Pharmaceutical Industries Ltd., Mylan N.V., and Purdue Pharma L.P.
Laxatives Market Taxonomy:
By Drug Type:
- Bulk-forming Agents
- Emollients (Stool Softeners)
- Lubricating Agents
- Stimulating Agents
- Hyperosmotic Agents
- Saline Laxative Agents
- Chloride Channel Activators
- Over-the-counter (OTC)
By Drug Type:
By Route of Administration:
Reasons to Purchase this Report
• To gain an in-depth understanding of Laxatives market globally
• To identify the on-going trends and anticipated growth in the next nine years
• To help industry consultants, Laxatives market other stakeholders align their market-centric strategies
• To obtain research-based business decisions and add weight to presentations and marketing strategies
• To gain competitive knowledge of leading market players
Table of Content
Global Laxatives Market Research Report
Section 1: Global Laxatives Industry Overview
Section 2: Global Economic Impact on Laxatives Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Laxatives Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Laxatives Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027